Oslo Pensjonsforsikring’s Biogen BIIB Stock Holding History

Oslo Pensjonsforsikring’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398K	Hold	1,840	–	–	0.05%	161
2026 Q1	$337K	Buy	+1,840	New	+$339K	0.05%	177

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oslo Pensjonsforsikring's BIIB Position: Q2 2026 in Review

Oslo Pensjonsforsikring held its Biogen (BIIB) position steady in Q2 2026 at 1,840 shares worth $398K. The position accounts for 0.05% of the portfolio, ranked #161.

Oslo Pensjonsforsikring first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 1,035 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Oslo Pensjonsforsikring held 1,840 shares of Biogen worth $398K as of Q2 2026.
Oslo Pensjonsforsikring left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.05% of Oslo Pensjonsforsikring's portfolio in Q2 2026, its #161 holding.
Oslo Pensjonsforsikring first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
1,035 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Oslo Pensjonsforsikring's 13F filing for Q2 2026, filed 31 Jul 2026.